EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Role of SEL1L in the progression of solid tumors, with a special focus on its recent therapeutic potential

Darmadi Darmadi, Raed Obaid Saleh, Enwa Felix Oghenemaro, Maha Noori Shakir, Ahmed Hjazi, Zahraa F Hassan, Ahmed Hussein Zwamel, Sanoeva Matlyuba, Mahamedha Deorari, Shamam Kareem Oudah

Cell Biology International · 2025

DOI: 10.1002/cbin.12242 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Biology International, 2025. Verfasst von Darmadi Darmadi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 111 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since suppressor/enhancer of Lin‐12‐like (SEL1L) was cloned in 1997, various pieces of evidence from lower species suggest it plays a significant role in protein degradation via the ubiquitin‐proteasome system. The relevance of SEL1L in many aspects of malignant transformation and tumorigenic events has been the subject of research, which has shown compelling in vitro and in vivo findings relating its altered expression to changes in tumor aggressiveness. The Endoplasmic Reticulum (ER) in tumor cells is crucial for preserving cellular proteostasis by inducing the unfolded protein response (UPR), a stress response. A crucial component of the UPR is ER‐associated degradation (ERAD), which guards against ER stress‐induced apoptosis and the removal of unfolded or misfolded proteins by the ubiquitin‐proteasome system. As a protein stabilizer of HMG‐CoA reductase degradation protein 1 (HRD1), one of the main components of ERAD, SEL1L plays an important role in ER homeostasis. Notably, the expression levels of these two proteins fluctuate independently in various cancer types, yet changes in their expression affect the levels of other associated proteins during cancer pathogenesis. Recent studies have also outlined the function of SEL1L in cancer medication resistance. This review explores the value of targeting SEL1L as a novel treatment approach for cancer, focusing on the molecular processes of SEL1L and its involvement in cancer etiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansAnimalsDisease ProgressionEndoplasmic Reticulum-Associated DegradationUnfolded Protein ResponseEndoplasmic ReticulumEndoplasmic Reticulum StressProteins

Stichwörter der Autor:innen

Cancer aggressivenessCancer therapySEL1Lproteostasisubiquitin‐proteasome systemunfolded protein response

Substanzen

SEL1L protein, humanProteins

Autor:innen und Institutionen

  • Department of Internal Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.
  • Department of Medical Laboratory Techniques, Al-Maarif University College, Al-Anbar, Iraq.
  • Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Delta State University, Abraka, Nigeria.
  • Department of Medical Laboratories Technology, AL-Nisour University College, Baghdad, Iraq.
  • Department of Medical Laboratory, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia.
  • College of Dentistry, Al-Ayen University, Thi-Qar, Iraq.

Zitieren

APA

Darmadi, D., Saleh, R. O., Oghenemaro, E. F., Shakir, M. N., Hjazi, A., Hassan, Z. F., Zwamel, A. H., Matlyuba, S., Deorari, M., & Oudah, S. K. (2025). Role of SEL1L in the progression of solid tumors, with a special focus on its recent therapeutic potential. Cell Biology International. https://doi.org/10.1002/cbin.12242

Vancouver

Darmadi D, Saleh RO, Oghenemaro EF, Shakir MN, Hjazi A, Hassan ZF, et al. Role of SEL1L in the progression of solid tumors, with a special focus on its recent therapeutic potential. Cell Biology International. 2025. doi:10.1002/cbin.12242

BibTeX
@article{Darmadi2025,
  author = {Darmadi, Darmadi and Saleh, Raed Obaid and Oghenemaro, Enwa Felix and Shakir, Maha Noori and Hjazi, Ahmed and Hassan, Zahraa F and Zwamel, Ahmed Hussein and Matlyuba, Sanoeva and Deorari, Mahamedha and Oudah, Shamam Kareem},
  title = {Role of SEL1L in the progression of solid tumors, with a special focus on its recent therapeutic potential},
  journal = {Cell Biology International},
  year = {2025},
  doi = {10.1002/cbin.12242}
}
Kostenlos starten →